Manufacturing, Biologic Drugs

Global Health Challenges Spur Vaccine Development

October 02, 2011

Manufacturers fund research and reduce prices to tackle diseases.

Trends and Challenges in Biologics Outsourcing

October 01, 2011

In a quick-fire interview, Dr Stephen Taylor, Vice President & Commercial Director at Fujifilm Diosynth Biotechnologies, looks at some of the challenges facing biologics outsourcing.

White House Deficit Reduction Plan Targets Biologic Exclusivity Period

September 22, 2011

President Obama released his plan for deficit reduction on Sept. 19, 2011, and included in the 80-page report are several provisions that would affect US drug makers if enacted.

Building Technology Positions in API Manufacturing

September 01, 2011

As contract manufacturers and fine-chemical suppliers gather for CPhI/ICSE, effective strategies for technology differentiation are key in an increasingly competitive environment.

Prophylaxis in a Patch

August 02, 2011

New studies reveal the promise and feasibility of transdermal vaccine delivery.

Inside USP: International Dialogue on Biologics Standards

August 02, 2011

USP promotes horizontal standards for biologics' quality attributes.

Regulatory Roundup: FDA Approves the Influenza Vaccine Formulation for the 2011-2012 Flu Season

July 21, 2011

FDA Approves the Influenza Vaccine Formulation for the 2011-2012 Flu Season.

Technologies for Downstream Processing in Biologics

May 01, 2011

The author describes recent developments to help overcome the downstream processing bottleneck. This article is part of a special issue on Sterile Manufacturing and Bioprocessing.

Biosimilars Market will be Worth $3.7 Billion by 2015

March 31, 2011

The global market for biosimilars is set to grow from $243 million in 2010 to $3.7 billion in 2015, according to research from Datamonitor, an independent industry analyst company.

Novartis Acquires Chinese Vaccine Company

March 25, 2011

Novartis has completed the acquisition of a majority stake in Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.  one of the largest privately held vaccines companies in China.